Kerafast
Private Company
Total funding raised: $7.5M
Overview
Kerafast has established itself as a critical facilitator in the life sciences research supply chain by connecting reagent providers (primarily academic labs) with procurers (research scientists). The company's platform streamlines the legal and logistical complexities of material transfer, enabling the commercialization of reagents that would otherwise remain siloed within individual institutions. By aggregating a vast catalog of unique research tools, Kerafast addresses a key bottleneck in biomedical research, serving a global customer base that includes universities, government agencies, and biopharma companies. Its business model is based on revenue-sharing with the originating labs and institutions.
Technology Platform
Online marketplace and service platform for sourcing, licensing, and distributing unique biological research reagents from academic labs globally.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Kerafast competes in a fragmented segment of the life science tools market. Primary competitors include large, diversified distributors (e.g., Thermo Fisher Scientific, Merck Millipore) that also source some academic reagents, and specialized non-profit repositories like Addgene (for plasmids). Its key differentiator is a focused platform and service model dedicated entirely to the legal and logistical complexities of transferring unique materials from academia.